Topic: Pfizer Inc.
Will a fresh look at pain overcome drug barriers?
Reuters US Online Report Health News
LONDON (Reuters) - Barriers to understanding pain are starting to fall and scientists and drug firms say a fresh approach is producing potential new drugs to hit where it hurts. Millions of people across the world suffer chronic pain -- such as nerve, joint or muscle pain that lasts weeks, months or ...
Pfizer drug filings on track despite setbacks
Reuters US Online Report Business News
LONDON (Reuters) - It's been a bad month for Pfizer's <PFE.N> research labs but its head of R&D says the world's biggest drugmaker is on track to hit earlier targets for new drug filings despite the setbacks. "We have had some disappointments, there ...
Teva to buy Ratiopharm for nearly $5 billion
Reuters US Online Report Business News
FRANKFURT (Reuters) - Israel's Teva <TEVA.TA> has won the battle for German generic drugmaker Ratiopharm, paying an enterprise value of 3.625 billion euros to fix the industry leader's weakness in the world's second-largest generics market. Teva, which beat U.S. drugs powerhouse Pfizer < ...
Three-way Ratiopharm auction comes to head: sources
Reuters US Online Report Business News
FRANKFURT/COLOGNE (Reuters) - The tussle over German generic drugs maker Ratiopharm is drawing to a close as the three remaining contenders square off in the final round of bidding, sources close to the deal told Reuters on Wednesday. Pfizer <PFE.N> will submit its bid on Wednesday, a ...
Related Videos by 5min
on OneRiot
Related Photos by Flickr
